Published in Cancer Res on February 15, 2008
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med (2010) 3.61
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J (2011) 2.97
Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis. Mol Cell Biol (2008) 1.41
LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res (2009) 1.34
Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. Cancer Res (2009) 1.02
Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer. Am J Pathol (2010) 1.02
Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett (2014) 1.01
Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget (2014) 0.94
Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling. Mol Oncol (2014) 0.93
Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates. BMC Syst Biol (2008) 0.85
Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2. Oncogene (2013) 0.85
The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region. Cell Rep (2016) 0.85
Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene. Oncogenesis (2013) 0.85
Experimental animal model and RNA interference: a promising association for bladder cancer research. World J Urol (2009) 0.84
3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells. J Nutr (2008) 0.83
Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis. Int J Oncol (2013) 0.82
Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability. EBioMedicine (2016) 0.81
Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer. Int J Otolaryngol (2011) 0.80
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer. BMC Cancer (2010) 0.79
Direct interaction between AR and PAK6 in androgen-stimulated PAK6 activation. PLoS One (2013) 0.79
Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer. Oncotarget (2016) 0.78
Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells. Int J Oncol (2015) 0.78
The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study. Biomed Res Int (2015) 0.76
Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4. Cancer Biol Ther (2014) 0.76
Arrestin2 modulates androgen receptor activation. Oncogene (2014) 0.76
Combined treatment of PC-3 cells with ultrasound and microbubbles suppresses invasion and migration. Oncol Lett (2014) 0.75
Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion. Prostate (2015) 0.75
AR Signaling and the PI3K Pathway in Prostate Cancer. Cancers (Basel) (2017) 0.75
Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Sci Rep (2017) 0.75
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration. Sci Rep (2017) 0.75
Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med (2004) 3.84
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med (2010) 3.61
Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol (2002) 2.87
Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst (2009) 2.28
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst (2005) 2.23
Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer (2007) 2.13
Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate (2010) 1.78
Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res (2002) 1.58
Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score. BJU Int (2011) 1.49
Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol (2004) 1.47
Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res (2005) 1.43
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol Oncol (2009) 1.34
Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc (2011) 1.30
Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. Cancer Res (2005) 1.29
Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer. Pancreas (2005) 1.25
Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors. Clin Cancer Res (2008) 1.23
Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer. Clin Cancer Res (2004) 1.21
The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol (2008) 1.20
Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody. J Immunother (2007) 1.13
Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy. Radiology (2012) 1.13
A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther (2007) 1.13
Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors. Protein Eng Des Sel (2008) 1.11
Trefoil factor 3 is overexpressed in human prostate cancer. Prostate (2004) 1.09
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur J Nucl Med Mol Imaging (2010) 1.05
Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody. J Nucl Med (2014) 1.03
Peritoneal fixation prevents dislocation of Tenckhoff catheter. Perit Dial Int (2011) 1.02
Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci U S A (2001) 1.02
Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol (2003) 0.99
Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res (2005) 0.97
Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling. J Biol Chem (2004) 0.97
Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation. Prostate (2008) 0.95
Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers. Urology (2012) 0.94
Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol (2002) 0.92
Multidimensional MR spectroscopic imaging of prostate cancer in vivo. NMR Biomed (2013) 0.91
Stem cells in prostate and prostate cancer development. Urol Oncol (2006) 0.90
MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores. J Magn Reson Imaging (2012) 0.88
MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells. Proc Natl Acad Sci U S A (2013) 0.88
Role of prostate stem cell antigen in prostate cancer research. Curr Opin Urol (2002) 0.86
Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate (2003) 0.85
Radical prostatectomy: value of prostate MRI in surgical planning. Abdom Imaging (2012) 0.85
An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer. Appl Immunohistochem Mol Morphol (2006) 0.83
Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression. Urology (2003) 0.81
Molecular markers and prostate cancer prognosis. Clin Prostate Cancer (2004) 0.81
Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. J Urol (2003) 0.81
Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways. Urol Oncol (2009) 0.80
Risk stratification of prostate cancer in the modern era. Curr Opin Urol (2015) 0.80
Genetic alterations in prostate cancer. Curr Urol Rep (2004) 0.79
The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup study. J Urol (2008) 0.78
Improvements in prostate brachytherapy dosimetry due to seed stranding. Brachytherapy (2006) 0.77
Monoclonal antibody therapy for genitourinary oncology: promise for the future. J Urol (2002) 0.76
Nanoscale welding aerosol sensing based on whispering gallery modes in a cylindrical silica resonator. Opt Express (2015) 0.75
Analysis of radiation pressure induced nonlinear optofluidics. Opt Express (2014) 0.75
[ADRENAL HEMORRHAGE: 6 CASES AND A REVIEW OF 57 REPORTED CASES]. Nihon Hinyokika Gakkai Zasshi (2015) 0.75
Risk factors for clinical metastasis in men undergoing radical prostatectomy and immediate adjuvant androgen deprivation therapy. Asian Pac J Cancer Prev (2014) 0.75
The urologist role in basic and clinical translational research: Personal reflections of a urologic scientist. Urol Oncol (2009) 0.75
Fine-tuning robot-assisted radical prostatectomy planning with MRI. Urol Oncol (2011) 0.75
Measuring Contact Pressure of Lower Extremities in Patients Undergoing Robot-Assisted Radical Prostatectomy. Urol Int (2016) 0.75
Computed tomography for the management of exit-site and tunnel infections in peritoneal dialysis patients . Clin Nephrol (2016) 0.75
Endothelial miR-26a regulates VEGF-Nogo-B receptor-mediated angiogenesis. BMB Rep (2017) 0.75